WeightWatchers' CEO of roughly two years, Sima Sistani, is out. She helped push the company into the white-hot weight-loss ...

Shares of Weight Watchers parent company WW International (WW) rose nearly 40% after the company announced plans to begin ...

The decision by WeightWatchers to prescribe knockoff medication has turned the legendary brand into just another online ...

With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management ...

What’s going on with Weight Watchers? With the CEO stepping down ... members wonder what’s next for the company. Plus, the ...

High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...

The company renamed and rebranded itself as WW ... "doesn't bode well" because weight-loss drugs are replacing Weight Watchers for many people who are looking for ways to lose weight.

In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...

WEIGHT WATCHERS SAYS IT WILL NOW OFFER ELIGIBLE MEMBERS COMPOUNDED ... and Zepbound is $1,060, according to Lilly. The ...

WeightWatchers said it will sell compounded versions of semaglutide — the key ingredient in Novo Nordisk's Ozempic and Wegovy ...

WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...